Certified by Founder Lodge
Curevo Vaccine
United States - Bothell, Washington
START UP
1 Disclosed Funding Rounds $110,000,000
0 Participating Investments
-
Founded date
2017
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Curevo Vaccine is a clinical-stage developer of vaccines for varicella and herpes zoster. Amezosvatein (CRV-101) is an adjuvanted subunit (non-mRNA) vaccine designed to prevent herpes zoster,
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| March, 19 ,2025 | Series B | $110,000,000 |
OrbiMed
RA Capital Management, L.P.
Janus Henderson Investors
Adjuvant Capital
Medicxi
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Brellium | $13,700,000 | (Apr 22, 2025)
Terra Security | $7,500,000 | (Apr 22, 2025)
CSignum | $8,021,670 | (Apr 22, 2025)
ROH | $9,000,000 | (Apr 22, 2025)
GoldState Music | $500,000,000 | (Apr 22, 2025)
